KRYSTAL MILLER: Open Payments
NPI 1811263353 · PITTSBURG, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$155 in 9 payments from 6 companies in 2025. Trend: 2023 $194 · 2024 $236 · 2025 $155
Food & beverage: $155
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 3 | $50 |
| Lilly USA, LLC | 2 | $33 |
| Exact Sciences Corporation | 1 | $22 |
| AstraZeneca Pharmaceuticals LP | 1 | $17 |
| GlaxoSmithKline, LLC. | 1 | $16 |
| Kowa Pharmaceuticals America, Inc. | 1 | $15 |
Products named: MOUNJARO, Rybelsus, Cologuard Collection Kit, Ozempic, FARXIGA, TRELEGY ELLIPTA, ZORYVE.
Industry payments across TX — which companies pay providers there.
